Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TGTX
#1195
TG Therapeutics, Inc.
30.0
9
-0.36%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.36%
Monthly Change
-2.37%
6 month change
+5.28%
Year Change
+6.33%
Previous Close
30.2
0
Open
30.0
9
Bid
Ask
Low
30.0
9
High
30.0
9
Volume
136
Markets
US Stock Market
Healthcare
TGTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
140.59 M
142.82 M
146.36 M
154.42 M
157.07 M
—
Valuation ratios
Enterprise value
6.76 B
2.41 B
1.59 B
2.54 B
4.55 B
21.92 B
Price to earnings ratio
—
—
-7.92
189.33
200.67
466.05
Price to sales ratio
—
—
562.55
10.83
14.67
54.61
Price to cash flow ratio
—
—
8.89
80.56
119.11
405.93
Price to book ratio
—
—
0.5
15.77
21.7
39.82
Enterprise value to EBITDA ratio
—
—
—
121.78
108.29
330.68
Profitability ratios
Return on assets %
0.45
0.92
1.02
0.04
0.04
0.43
Return on equity %
0.54
1.47
3.39
0.08
0.11
0.78
Return on invested capital %
1 649.24
2 168.43
1 554.62
145.45
108.67
-220.6
Gross margin %
100
100
100
93.95
88.3
342.12
Operating margin %
180 K
5 154.28
6 924.2
8.83
12.74
60.52
EBITDA margin %
—
—
—
8.92
12.76
77.7
Net margin %
183.8 K
5 204.08
7 121.54
5.42
7.11
267.66
Liquidity ratios
Quick ratio
—
—
—
5.18
5.03
13.91
Current ratio
6.99
5.06
3.16
5.92
6.25
17.96
Inventory turnover
—
—
—
0.35
0.51
0.58
Asset turnover
0
0.01
0.01
0.89
0.73
0.78
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.01
0.18
0.37
0.3
0.42
1.38
Long term debt to total equity ratio
0
0.02
0.02
0.62
1.1
3.42
Per share metrics
Operating cash flow per share
—
—
1.3
0.21
0.25
0.43
EBIT per share
—
—
—
0.14
0.26
0.64
EBITDA per share
—
—
—
0.14
0.26
0.64
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
1.29
1.46
1.94
6.46
Net current asset value per share
—
—
1.24
2.14
3.53
15.3
Tangible book value per share
—
—
22.98
1.08
1.39
8.32
Working capital per share
—
—
0.85
1.78
2.97
11.72
Book value per share
—
—
22.99
1.08
1.39
8.32
News
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
TG earnings missed by $0.23, revenue topped estimates
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
TG Therapeutics faces earnings test as Briumvi growth accelerates
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
TG Therapeutics presents BRIUMVI data at ACTRIMS forum
TG Therapeutics stock maintains Buy rating at B.Riley on strong Briumvi growth
TG Therapeutics to present BRIUMVI data at ACTRIMS forum
Genmab: Darzalex Growth Fuels Rally, Upside Is Tight (NASDAQ: GMAB)
TG Therapeutics stock holds Overweight rating at Cantor Fitzgerald
TG Therapeutics Stock Rises 7% on Strong Q4 & 2025 Preliminary Results